Regulatory Intelligence Services
Providing Real-time Intelligence for Informed Regulatory Strategies and Data-driven Insights
Providing Real-time Intelligence for Informed Regulatory Strategies and Data-driven Insights
It can be a significant challengeof managing constantly evolving regulatory requirements, which vary across countries. Zenovel Regulatory Intelligence (RI) services provides entire platform for accessing global regulatory information, ensuring compliance and confidence in your operations.
In the highly regulated and fast-paced pharmaceutical sector, staying on top of trends is essential. Zenovel provides pharmaceutical firms with the necessary information to efficiently traverse the intricate regulatory landscape through its Regulatory Intelligence (RI) services. By ensuring that your pharmaceutical company adhere to international regulatory requirements, our complete RI services reduce risks and hasten market entrance.
Zenovel RI team focuses on providing accurate and relevant regulatory information for successful market entry. We address focused queries, provide an overview of targeted countries’ regulations, and assess regulatory needs before product registration, tailoring solution to meet the diverse needs of global pharmaceutical and biopharmaceutical companies.
It involves the process of collecting data from various sources, staying updated on regulations, and analysing the information to understand its impact on products and strategies, assessing trends, potential regulatory hurdles, and opportunities.
It involves analysing regulatory strategies, planning product development, submissions, and post-approval activities to ensure compliance. Further, with the help of risk management process we identify and mitigate risks, anticipate challenges, and develop contingency plans to prevent regulatory challenges.
It involves approach such as disseminating regulatory information and recommendations to internal stakeholders, coordinating strategies across R&D, clinical, and commercial teams for informed decision-making.
It involves monitoring regulatory changes, updating labelling, safety reporting, and manufacturing practices to ensure on-going product compliance.
It involves monitoring regulatory activities and competitor submissions to understand the competitive landscape and make necessary adjustments to strategies.
Offer comprehensive training and updates on regulatory requirements and changes to ensure your team is well-informed about the implications for their work.
We ensure compliance with all legal criteria can significantly reduce the likelihood of delays or rejections in your process.
We have access to a robust information base for making well-informed judgments about product development and market entry.
We detect potential regulatory issues effective preventative management and mitigation.
We stay updated with regulatory strategies and potential market trends of your competitors.
We focus on areas where regulations have the most significant impact on efficient resource allocation.
The European Union’s Good Manufacturing Practice (GMP) standards, as outlined in the Annex to the Guide to Good Manufacturing Practice for Medicinal Products, ensure the quality and safety of medicinal products, including those used in clinical trials. The Qualified Person (QP) plays a crucial role in batch certification, particularly for
In the intricate process of developing new pharmaceuticals, guaranteeing product safety, effectiveness, and adherence to global regulations is essential. Batch release testing acts as a pivotal quality assurance measure, confirming that medications comply with rigorous criteria before distribution. When combined with International Council for Harmonisation (ICH) standards, this testing framework
In the world of life sciences, quality isn’t just a benchmark—it’s the backbone of success. Three key pillars—Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP)—form the core framework that supports everything from product development to regulatory approval. These standards aren’t just industry buzzwords; they’re the
In the pharmaceutical industry, quality is paramount—and at Zenovel, we are deeply committed to delivering excellence in Quality Assurance (QA). Our focus is on ensuring that every medicine is developed, manufactured, and delivered with safety and reliability as top priorities. QA is embedded in every stage of the pharmaceutical lifecycle—from
The U.S. Food and Drug Administration (FDA) emphasize the importance of data integrity in pharmaceutical manufacturing, particularly under its Current Good Manufacturing Practices (CGMP) rules. However, issues like fake lab results and sloppy record-keeping persist, posing risks to patients and losing confidence in the system. Independent oversight is crucial to
In the rapidly evolving pharmaceutical industry, assuring product quality and customer safety is a need. This endeavour continues to be based on validation, a methodical procedure to verify that manufacturing procedures and equipment consistently deliver high-quality outcomes. A strong strategy to validation is required in 2025 due to the complexity
